Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection

– Roche led the financing alongside existing and new investors – – The funds will progress clinical programs and expand platform capabilities – SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 /PRNewswire/ — Freenome, a biotechnology company developing blood tests for early cancer detection,…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks